Arterys Raises $28 Million to Accelerate the Delivery of Medical AI to Practices Around the World
San Francisco, CA -- Arterys, a leading global medical imaging platform to deliver clinical AI products over the internet, just received its seventh USA FDA clearance and announced its latest round of funding — a $28 million Series C investment from a syndicate led by Benslie Investment Group and Temasek Holdings, with participation by Fosun, Revelation Partners, Emergent Medical Partners, and Varian Medical Systems.
Arterys said it will deploy this new round of financing to broaden the Arterys ecosystem, comprising a broad set of partners on the new Arterys Marketplace working together to deliver clinical applications built on the Arterys cloud-native viewer and platform. A particular focus will be to accelerate partners’ efforts to bring new clinical-grade AI applications to providers by extending its proprietary technology platform to application partners thereby making it easier for clinicians to integrate AI into their workflows from a single interface.
“The current crisis has shown us the necessity of a different approach to providing healthcare, where technology and AI are crucial for future success. Arterys is committed to transforming the way AI is integrated into the medical workflow, a promise that is long due in the industry. We recently launched our cloud platform and marketplace that will consolidate the work of thousands of AI models to be readily available for use by healthcare institutions around the globe,” said Henry Weinstein, Managing Partner at Benslie International Ltd.
Arterys has appointed John Axerio-Cilies, co-founder, as the acting CEO. “We realize that we can’t transform the healthcare system alone,” says Axerio-Cilies. “No company can. And now, the same technology and strengths that we’ve leveraged to build our core products [Arterys Cardio AI and Arterys Lung AI] are now available to medical innovators at companies and universities around the world — they can benefit from regulatory support, channel partnerships, performance, security, and best-in-class hospital system integrations.”
Interested in bringing a unified AI experience to your practice? Start today by reaching out to John Axerio-Cilies via info@arterys.com.
Related news
-
Radiology partners selects Aidoc to Accelerate the use of AI as the standard of Care in Radiology
Radiology Partners (RP), the leading radiology practice in the U.S., announced today that it has selected Aidoc, the leading provider of artificial intelligence (AI) solutions for medical imaging, to offer unparalleled AI capabilities to its hospitals and health systems, and to accelerate the adoption of AI as the standard of care in radiology. “AI has the potential to unlock enormous value for the entire healthcare ecosystem, and I believe our partnership with Aidoc will turn out to be the tipping point...
-
CEO of Leading Teleradiology provider joins Aidoc to Support european expansion
Aidoc, the leading provider of AI solutions for medical imaging, announced today the hire of Alexander Böhmcker to head up the expansion of Aidoc’s European Division alongside Jeremy De Sy, Director of Sales Europe. Prior to joining Aidoc, Böhmcker had spent over a decade as the CEO of Telemedicine Clinic (TMC), a leading pan-European Teleradiology and pathology-reporting provider with a network of over 300 sub-specialized doctors, serving over a 100 European hospitals. “I am really excited...
-
Kayan Health Partners with Predictiv Care, Inc. to Offer DNA-based and AI Powered Medical Consultations
Beyond Medical Technologies Inc. (“Beyond Medical” or the “Company“) (CSE: DOCT) (Frankfurt: 7FM3), is pleased to state that further to its news release dated January 14, 2021, announcing its letter of intent with Kayan Health Limited (“Kayan Health“), Kayan Health has signed a Memorandum of Understanding (“MoU”) with Predictiv Care, Inc. (“Predictiv”), a personalized genomics technology platform aimed at empowering healthcare professionals with predictive...
-
Nanox and USARAD Introduce Radiology AI Second Opinion Program
NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces an extension of its strategic collaboration with USARAD Holdings Inc., a US Joint Commission accredited teleradiology and telemedicine company, to launch an advanced radiology diagnostics service combining over 300 expert radiologists and artificial intelligence (AI) decision support algorithms and solutions. In February 2020, Nanox and USARAD originally announced...
-
AIDOC and IMBIO partner to provide an industry first ai solution to prioritize suspected pulmonary embolism and automatically calculate RV/LV ratio
Aidoc, the leading provider of enterprise AI solutions, and Imbio, a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality of pulmonary embolism detection and treatment. “Achieving the value of AI in clinical practice requires end-to-end solutions which consolidate the various AI results and...
Customer comments
No comments were found for Arterys Raises $28 Million to Accelerate the Delivery of Medical AI to Practices Around the World. Be the first to comment!